Menu
Be a Change Agent, Not a Secret Agent
Be a Change Agent, Not a Secret Agent
As the healthcare industry evolves into an ecosystem of data-rich, digitally enabled stakeholders, drug manufacturers are losing their informational advantage in the value chain.
To stay vital, sponsors are beginning to embrace an operating model based on collaboration, openness, and trust, with many moving toward actively sharing sensitive health data with partners.
In this panel, Sarah Lyons, General Manager, Privacy Analytics and Tom Baker, VP Consulting, Europe, Middle East, Africa (EMEA), IQVIA explore the implications of this new ecosystem, focusing on the data platform as a launchpad for innovation that benefits everyone and advances patient health.
Be a Change Agent, Not a Secret Agent
As the healthcare industry evolves into an ecosystem of data-rich, digitally enabled stakeholders, drug manufacturers are losing their informational advantage in the value chain.
To stay vital, sponsors are beginning to embrace an operating model based on collaboration, openness, and trust, with many moving toward actively sharing sensitive health data with partners.
In this panel, Sarah Lyons, General Manager, Privacy Analytics and Tom Baker, VP Consulting, Europe, Middle East, Africa (EMEA), IQVIA explore the implications of this new ecosystem, focusing on the data platform as a launchpad for innovation that benefits everyone and advances patient health.
Situation: California’s Consumer Privacy Act inspired Comcast to evolve the way in which they protect the privacy of customers who consent to share personal information with them.
Situation: Integrate.ai’s AI-powered tech helps clients improve their online experience by sharing signals about website visitor intent. They wanted to ensure privacy remained fully protected within the machine learning / AI context that produces these signals.
Situation: Novartis’ digital transformation in drug R&D drives their need to maximize value from vast stores of clinical study data for critical internal research enabled by their data42 platform.
Situation: CancerLinQ™, a subsidiary of American Society of Clinical Oncology, is a rapid learning healthcare system that helps oncologists aggregate and analyze data on cancer patients to improve care. To achieve this goal, they must de-identify patient data provided by subscribing practices across the U.S.
Situation: Needed to ensure the primary market research process was fully compliant with internal policies and regulations such as GDPR.
Situation: Needed to enable AI-driven product innovation with a defensible governance program for the safe and responsible use
of voice-to-text data under Shrems II.
This course runs on the 2nd Wednesday of every month, at 11 a.m. ET (45 mins). Click the button to register and select the date that works best for you.
